BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28384594)

  • 1. Vascular closure devices in stroke patients receiving tissue plasminogen activator: A retrospective analysis from an academic tertiary medical center and a teaching community hospital stroke database.
    Patil MS; Jayaraman MV; Ahn SH
    Clin Neurol Neurosurg; 2017 Jun; 157():22-24. PubMed ID: 28384594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined full-dose IV and endovascular thrombolysis in acute ischaemic stroke.
    Bhatia R; Shobha N; Menon BK; Bal SP; Kochar P; Palumbo V; Wong JH; Morrish WF; Hudon ME; Hu W; Coutts SB; Barber PA; Watson T; Goyal M; Demchuk AM; Hill MD
    Int J Stroke; 2014 Dec; 9(8):974-9. PubMed ID: 23013039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of endovascular versus intravenous thrombolytic treatment for acute ischemic stroke in dialysis patients.
    Saeed F; Adil MM; Piracha BH; Qureshi AI
    Int J Artif Organs; 2014 Oct; 37(10):727-33. PubMed ID: 25262635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt.
    Boehme AK; Rawal PV; Lyerly MJ; Albright KC; Bavarsad Shahripour R; Palazzo P; Kapoor N; Alvi M; Houston JT; Harrigan MR; Cava L; Sisson A; Alexandrov AW; Alexandrov AV
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2001-2006. PubMed ID: 25113079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Endovascular Treatment in Intravenous Tissue Plasminogen Activator-Ineligible Patients.
    Rebello LC; Haussen DC; Grossberg JA; Belagaje S; Lima A; Anderson A; Frankel MR; Nogueira RG
    Stroke; 2016 Apr; 47(4):1131-4. PubMed ID: 26906918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience.
    Lattimore SU; Chalela J; Davis L; DeGraba T; Ezzeddine M; Haymore J; Nyquist P; Baird AE; Hallenbeck J; Warach S;
    Stroke; 2003 Jun; 34(6):e55-7. PubMed ID: 12750543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis.
    Kurowski D; Jonczak K; Shah Q; Yaghi S; Marshall RS; Ahmad H; McKinney J; Torres J; Ishida K; Cucchiara B
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1104-1109. PubMed ID: 28110890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assurance monitoring of a citywide transportation protocol improves clinical indicators of intravenous tissue plasminogen activator therapy: a community-based, longitudinal study.
    Atsumi C; Hasegawa Y; Tsumura K; Ueda T; Suzuki K; Sugiyama M; Nozaki H; Suzuki S; Nakane M; Nagashima G; Kitamura T; Nikaido H; Sasanuma J
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):183-8. PubMed ID: 25440326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Thrombolysis for Acute Ischemic Stroke After Recent Myocardial Infarction: Case Series and Systematic Review.
    Marto JP; Kauppila LA; Jorge C; Calado S; Viana-Baptista M; Pinho-E-Melo T; Fonseca AC
    Stroke; 2019 Oct; 50(10):2813-2818. PubMed ID: 31436141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
    Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
    J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke Neurologist's Perspective on the New Endovascular Trials.
    Grotta JC; Hacke W
    Stroke; 2015 Jun; 46(6):1447-52. PubMed ID: 25944328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.
    Daffertshofer M; Gass A; Ringleb P; Sitzer M; Sliwka U; Els T; Sedlaczek O; Koroshetz WJ; Hennerici MG
    Stroke; 2005 Jul; 36(7):1441-6. PubMed ID: 15947262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.